XIX International AIDS Conference. Interview with Bernhard Schwartzlander from UNAIDS in Geneva. Schwartzländer is an expert on the statistics of HIV/AIDS. He talks about the HIV prevalence globally and the importance of early diagnosis and ARV treatment.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Swedish Dr Lars Olof Kallings who founded the International AIDS Society (IAS) in 1988 and who is now the United Nations Special Envoy for AIDS in Eastern Europe, reflects on the history of the AIDS movement.

XVII International AIDS Conference in Mexico City. Interview with Dr Mervyn Silverman from San Francisco, who has been active in the AIDS movement since the early 80's. Here he reflects on the leadership of UNAIDS Director Peter Piot.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Sten Vermund from University of Alabama reflects on the history of the global AIDS epidemic and his involvement in the field as a young scientist in the 80's. He discusses the social and economic factors of HIV/AIDS, such as stigma, poverty and the drug industry.